Loading…
Loading…
As of 20 Nov 2026: Centenial Surgical Suture ₹100.63 (m-cap ₹36.23 Cr) vs Earkart ₹102.00 (m-cap ₹141 Cr, P/E 28.5). Compare ROE, ROCE, growth, debt, dividends and 1-year returns.
As of · NSE prices; ratios from company filings
| Metric | Centenial Surgical Suture | Earkart |
|---|---|---|
| Share price | ₹100.63 | ₹102.00 |
| Day change | +5.00% | 0.00% |
| Market cap | ₹36.23 Cr | ₹141 Cr |
| P/EPrice ÷ trailing 12-month earnings per share; blank for a loss. | — | 28.5 |
| P/BPrice ÷ book value per share. | 1.3 | 2.2 |
| ROEReturn on equity. | -7.4% | — |
| ROCEReturn on capital employed. | 2.5% | — |
| Sales growth (3Y CAGR) | 0.7% | 23.2% |
| Profit growth (3Y CAGR) | — | 55.6% |
| Debt to equity | 0.38 | 0.00 |
| Dividend yield | 0.00% | 0.00% |
| 1-year price return | −0.7% | −50.2% |
| Promoter holding | 46.9% | 57.3% |
| Industry | Medical Equipment & Supplies | Medical Equipment & Supplies |
Open in the compare tool for price charts from one month to five years, scorecards and more companies.
Each line states which company has the higher or lower figure; none of them is a recommendation.
Earkart Limited is larger, with a market cap of ₹141 Cr against ₹36.23 Cr for Centenial Surgical Suture Ltd as of 20 Nov 2026 — about 3.9 times the size.
Centenial Surgical Suture Ltd has no meaningful P/E right now (a loss over the last twelve months, or no reported earnings), so the two cannot be compared on P/E.
Jivani Markets does not give buy, sell or hold recommendations and is not a SEBI-registered investment adviser or research analyst. The table on this page lays out the facts side by side — price, valuation, returns on capital, growth, debt, dividends and promoter holding — so you can weigh them against your own goals, or with a SEBI-registered adviser.
Prices refresh every few minutes during market hours and ratios update when the companies report results. Each number is the same one shown on the two stock pages.